Measuring the impact of new housing programs on HIV risk and drug use.
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
This study is looking at how new housing programs in Boston can help people experiencing homelessness stay healthier and safer, especially regarding HIV and drug use, by providing important resources like clean syringes and naloxone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brandeis University NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project ID | NIH-10831058 on NIH RePORTER |
What this research studies
This research investigates how novel harm reduction housing programs in Boston affect the health and safety of individuals experiencing homelessness, particularly in relation to HIV risk, treatment uptake, and drug use. By utilizing a mixed methods approach, the study aims to gather data on the experiences of residents in these housing programs, which provide essential resources like sterile syringes and naloxone. The research will analyze both the positive and negative outcomes of these interventions, focusing on how different housing models influence health behaviors and access to care.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing homelessness who are at risk for HIV and substance use issues.
Not a fit: Patients who are not experiencing homelessness or who do not have substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved housing strategies that enhance health outcomes for individuals at risk of HIV and substance use disorders.
How similar studies have performed: Previous research has shown mixed results regarding the effectiveness of harm reduction strategies, indicating both potential benefits and challenges, making this study particularly relevant.
Where this research is happening
Waltham, United States
- Brandeis University — Waltham, United States (Active)
Researchers
- Principal investigator: Green, Traci C — Brandeis University
- Study coordinator: Green, Traci C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.